Roffman Miller Associates Inc. PA Sells 1,023 Shares of Danaher Co. (NYSE:DHR)

Roffman Miller Associates Inc. PA trimmed its position in shares of Danaher Co. (NYSE:DHR) by 2.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 40,765 shares of the conglomerate’s stock after selling 1,023 shares during the period. Roffman Miller Associates Inc. PA’s holdings in Danaher were worth $9,358,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. AMF Tjanstepension AB bought a new position in Danaher in the third quarter worth about $5,923,000. Howard Capital Management Group LLC raised its stake in Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after buying an additional 48 shares in the last quarter. Dakota Wealth Management raised its stake in Danaher by 1.0% in the third quarter. Dakota Wealth Management now owns 8,161 shares of the conglomerate’s stock worth $2,269,000 after buying an additional 82 shares in the last quarter. Allworth Financial LP raised its stake in Danaher by 6.1% in the third quarter. Allworth Financial LP now owns 5,337 shares of the conglomerate’s stock worth $1,484,000 after buying an additional 307 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in Danaher by 3.8% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 79,222 shares of the conglomerate’s stock worth $21,821,000 after buying an additional 2,879 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Up 0.9 %

NYSE:DHR opened at $209.86 on Monday. The company has a market cap of $151.58 billion, a PE ratio of 39.75, a P/E/G ratio of 2.66 and a beta of 0.83. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company’s 50 day moving average is $226.71 and its two-hundred day moving average is $246.84.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the company posted $2.09 EPS. Analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.32 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. Danaher’s payout ratio is currently 20.45%.

Analysts Set New Price Targets

A number of research firms recently issued reports on DHR. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. The Goldman Sachs Group set a $250.00 price objective on shares of Danaher in a report on Wednesday, January 15th. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a report on Friday, December 13th. Robert W. Baird cut their price objective on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Guggenheim assumed coverage on shares of Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price objective on the stock. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $278.00.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.